VOQUILY® (melatonin - immediate release) 3mg

VOQUILY® is indicated for:
Sleep disorders in children and adolescents aged 6 to 18 years with neurodevelopmental disorders, including autism spectrum disorder (ASD) and attention deficit hyperactivity disorder (ADHD), where sleep hygiene measures have been insufficient; and short-term treatment of jet lag in adults aged 18 years and over.
VOQUILY® 1 mg/mL oral solution; 2 mg, 3 mg, 5 mg capsules